New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

OZEMPIC (semaglutide) injection

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call at 9891296838 or Email to discuss.

Facts of Ozempic (semaglutide)

OZEMPIC® (semaglutide) injection, for subcutaneous use
Initial U.S. Approval: 2017
Injection: 2 mg/1.5 mL (1.34 mg/mL) available in:
•Single-patient-use pen that delivers 0.25 mg or 0.5 mg per injection (3).
•Single-patient-use pen that delivers 1 mg per injection (3).
Company: Novo Nordisk Inc.

South Delhi Pharma can facilitate patients and physicians access to commercially approved medicines, “Ozempic (semaglutide) ” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Ozempic (semaglutide) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Categories ,
Categories ,

Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:

Query Form


What Ozempic is?

Ozempic® (semaglutide) injection 0.5 mg or 1 mg is an injectable prescription medicine used:

  • along with diet and exercise to improve blood sugar in adults with type 2 diabetes.
  • to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes with known heart disease.

What semaglutide is?

Semaglutide (trade names Rybelsus, Ozempic) is a medication used for the treatment of type 2 diabetes. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) so that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.

Related Products